Metraipolis › archive › dc_f778c5bf8d32

In silico investigation of thiazole-semicarbazide hybrids as dual GSK-3β/Tau inhibitors for Alzheimer's disease — Europe PMC PMID:42236499

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42236499
DOI
10.1038/s41598-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-10-31T20:36:55.902Z
SHA-256 of the archived text
6b8d65229f404bf26ea6537ef618fa2214451d2fd936c87bd80dc394cb1a27e1
Stable URL of this page
https://metraipolis.com/documento/dc_f778c5bf8d32

How to cite

In silico investigation of thiazole-semicarbazide hybrids as dual GSK-3β/Tau inhibitors for Alzheimer's disease — Europe PMC PMID:42236499 — Europe PMC (en), https://europepmc.org/article/MED/42236499 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f778c5bf8d32 (Metraipolis archive dc_f778c5bf8d32, sha256 6b8d65229f404bf26ea6537ef618fa2214451d2fd936c87bd80dc394cb1a27e1)
BibTeX
@misc{dcf778c5bf8d32,
  title = {In silico investigation of thiazole-semicarbazide hybrids as dual GSK-3β/Tau inhibitors for Alzheimer's disease — Europe PMC PMID:42236499},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42236499},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f778c5bf8d32; sha256 6b8d65229f404bf26ea6537ef618fa2214451d2fd936c87bd80dc394cb1a27e1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42236499. Agents can read the archived copy with the MCP tool read_document.